#NewHire: Join us in welcoming Julie Friedman as our new VP of Therapeutic Operations & Program Management! Julie brings 30+ years of experience at both small and large Pharma/Biotech companies and we are so happy to have her on our team!
#BioPharma#Leadership#AI#LifeScience
We are building a new kind of biopharma company by putting the patient first. Our model shines a light on which therapy will work best for each patient.
Learn more: https://t.co/aBVRQoYtZO
#BioPharma#AI#LifeScience
Endpoint Health is built for the new era of precision medicine. We start with deep patient insight to identify unmet medical needs, then we identify the molecules most likely to be effective for each patient.
Learn more: https://t.co/iK22m4jNEd
#Innovation#AI#BioPharma
Proud of @endpointhealth’s newest precision immunology program! A first-in-class therapy…an innovative AI platform for patient selection. Our aim: transform immune-mediated inflammatory disease treatment with novel precision medicine strategies.
Read more https://t.co/ckwE9O8cj0
At @endpointhealth, we use a Patient-First approach with a mission to develop precision therapies that have the potential to improve outcomes for patients with immune-mediated diseases.
Learn more: https://t.co/aBVRQoGT8g
I love learning about how our talented team members grow when they’re both in and outside of the office. So excited that Dr. Ransi Somaratne has joined our team!
We are pioneering a new precision immunology ecosystem at @endpointhealth that mobilizes the clinical and data partners necessary to advance precision-first therapeutics for both acute and chronic immune-mediated diseases.
Click to Learn more: https://t.co/Mv8ccgFLAz
Today @endpointhealth joined the exclusive @ycombinator Top Companies list. I am so proud of our company and the employees who have worked tirelessly to qualify us for this incredible industry recognition.
Read more here: https://t.co/tXO9fnq6CP
I was honored to be interviewed for the @Labiotech_eu Beyond Biotech podcast about @endpointhealth, our robust pipeline, and our bright future. Thank you for a great dialogue!!
Check out the interview here: https://t.co/91l7Z8F5fH
At @endpointhealth, our vision is a world in which all patients get the best treatment possible for their unique biology and disease. Check out our precision-first approach to successfully deliver personalized treatment for patients: https://t.co/L8nwpNOK07
@endpointhealth aims to bring targeted therapies to patients as quickly as possible. Our goal is to improve the lives of people with immune-mediated illnesses and reduce the time it takes to find a medicine that works for them.
Learn more about us: https://t.co/QXxg2hg13Z
I was honored to speak at @SynBioBeta's Built with Biology conference about the precision medicine ecosystem. At @endpointhealth we differentiate ourselves by in-licensing and developing therapies, always focusing on the patient.
Watch more here: https://t.co/eraSbWgLZc
As a CEO, I am proud of the incredible team we’ve been building here at @endpointhealth. This group of seasoned industry professionals is succeeding both at and away from their desks – visit our site to find out what makes them unique: https://t.co/BNvay4n9OB
Great people are the key to great success. At Endpoint Health, we’re building a talented team of individuals with incredible achievements, both personally and professionally.
Get to know them now! Together, we’re building a new kind of biopharma: https://t.co/NfKDKQdBwZ
An article published today in Forbes offers leadership advice from our very own @DiegoARey, member of the @ForbesTechCncl. Diego tells leaders they shouldn’t be hesitant to launch a company, even if they don't have a fully developed idea. @ForbesCouncils https://t.co/xPDHnwW9d8
By rewriting the molecule-first drug development model, @endpointhealth aims to deliver #precisionfirst therapeutics that have the potential to improve outcomes for patients with immune-mediated diseases. Learn more: https://t.co/JwzyU3FgmW
I had the privilege to speak with @rafecooks and the "Talking Precision Medicine" podcast about Endpoint Health's work in precision immunology, insights on founding a company and how to build the right team. Check it out!
Our CEO and co-founder @EPHJason joined the “Talking Precision Medicine” podcast to discuss our work in precision immunology, founder lessons and our approach to building the right team. Give it a listen: https://t.co/omwRAFaEu0
As we head into the weekend, I’m excited to spend some quality time with my family. Wishing those of you celebrating #FathersDay, including my fellow “working dads” at @endpointhealth, a happy and relaxing holiday.
Exciting to see our Series A financing highlighted by @Nasdaq in New York! We’re extremely proud of this milestone and grateful to all those supporting us on the mission to improve outcomes for patients.
We care about each and every patient at @endpointhealth, which is why we are working to develop therapies designed for patients’ unique clinical needs. Learn more here - https://t.co/aBVRQoGT8g
At Endpoint Health, we’re patient-first, not molecule-first.
We are uniquely built to develop and commercialize both targeted therapeutics and therapy-guiding tests that offer patients the potential to receive a therapy personalized to their biology and clinical needs.
We are proud to announce that we closed $52 million in equity and debt financing in our Series A. Read more about how these funds will accelerate our mission to deliver new precision therapies to patients in need.
We’re thrilled to announce that we closed $52 million in equity and debt financing in our Series A to expand and progress our precision immunology pipeline. Read more in our press release here: https://t.co/Q047QaV04Q